252 related articles for article (PubMed ID: 23221866)
41. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
Dahmer MK; Senogles SE
J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
[TBL] [Abstract][Full Text] [Related]
42. Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.
Hassani OK; Féger J
Neuroscience; 1999; 92(2):533-43. PubMed ID: 10408602
[TBL] [Abstract][Full Text] [Related]
43. Acid stress induces a D1-like dopamine receptor in pituitary MSH cells of Oreochromis mossambicus.
Lamers AE; Ter Brugge PJ; Flik G; Wendelaar Bonga SE
Am J Physiol; 1997 Jul; 273(1 Pt 2):R387-92. PubMed ID: 9249576
[TBL] [Abstract][Full Text] [Related]
44. D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats.
Borowsky B; Kuhn CM
Neuropharmacology; 1992 Jul; 31(7):671-8. PubMed ID: 1328919
[TBL] [Abstract][Full Text] [Related]
45. Gestational exposure to cocaine or pharmacologically related compounds: effects on behavior and striatal dopamine receptors.
Stewart CW; Scalzo FM; Valentine J; Holson RR; Ali SF; Slikker W
Life Sci; 1998; 63(22):2015-22. PubMed ID: 9839545
[TBL] [Abstract][Full Text] [Related]
46. Role of D1 and alpha1 receptors in the enhanced locomotor response to dopamine D2-like receptor stimulation induced by repeated electroconvulsive shock.
D'Aquila PS; Collu M; Gessa GL; Serra G
J Psychopharmacol; 1997; 11(1):41-4. PubMed ID: 9097892
[TBL] [Abstract][Full Text] [Related]
47. Role of dopamine D1 and D2 receptors in the nucleus accumbens in jaw movements of rats: a critical role of the shell.
Cools AR; Miwa Y; Koshikawa N
Eur J Pharmacol; 1995 Nov; 286(1):41-7. PubMed ID: 8566150
[TBL] [Abstract][Full Text] [Related]
48. Naltrexone, dopamine receptor agonists and antagonists, and food intake in rats: 1. Food deprivation.
Hobbs DJ; Koch JE; Bodnar RJ
Pharmacol Biochem Behav; 1994 Sep; 49(1):197-204. PubMed ID: 7816874
[TBL] [Abstract][Full Text] [Related]
49. Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat.
Ainsworth K; Smith SE; Sharp T
J Psychopharmacol; 1998; 12(3):252-7. PubMed ID: 10958251
[TBL] [Abstract][Full Text] [Related]
50. Contralateral turning elicited by unilateral stimulation of dopamine D2 and D1 receptors in the nucleus accumbens of rats is due to stimulation of these receptors in the shell, but not the core, of this nucleus.
Koshikawa N; Kitamura M; Kobayashi M; Cools AR
Psychopharmacology (Berl); 1996 Aug; 126(3):185-90. PubMed ID: 8876017
[TBL] [Abstract][Full Text] [Related]
51. Evidence for specific involvement of dopamine D1 and D2 receptors in the regulation of body temperature in the rat.
Salmi P; Jimenez P; Ahlenius S
Eur J Pharmacol; 1993 Jun; 236(3):395-400. PubMed ID: 8102971
[TBL] [Abstract][Full Text] [Related]
52. Do D1/D2 interactions regulate prepulse inhibition in rats?
Wan FJ; Taaid N; Swerdlow NR
Neuropsychopharmacology; 1996 Apr; 14(4):265-74. PubMed ID: 8924194
[TBL] [Abstract][Full Text] [Related]
53. Basal forebrain histaminergic transmission modulates electroencephalographic activity and emergence from isoflurane anesthesia.
Luo T; Leung LS
Anesthesiology; 2009 Oct; 111(4):725-33. PubMed ID: 19741500
[TBL] [Abstract][Full Text] [Related]
54. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.
Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
Psychopharmacology (Berl); 1995 Feb; 117(4):403-12. PubMed ID: 7604140
[TBL] [Abstract][Full Text] [Related]
55. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
Hu XT; Brooderson RJ; White FJ
Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
[TBL] [Abstract][Full Text] [Related]
56. Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors.
Dall'Olio R; Gaggi R; Voltattorni M; Tanda O; Gandolfi O
Behav Pharmacol; 2002 Dec; 13(8):633-8. PubMed ID: 12478213
[TBL] [Abstract][Full Text] [Related]
57. Effects of selective dopamine receptor compounds on single, spontaneously-active neostriatal neurons.
Nantwi KD; Schoener EP
Gen Pharmacol; 1994 Nov; 25(7):1439-43. PubMed ID: 7896058
[TBL] [Abstract][Full Text] [Related]
58. Comparison of the stimulus properties of a pre- vs. a putative postsynaptic dose of quinpirole.
Cory-Slechta DA; Zuch CL; Fox RA
Pharmacol Biochem Behav; 1996 Nov; 55(3):423-32. PubMed ID: 8951984
[TBL] [Abstract][Full Text] [Related]
59. Inhibitory action of dopamine involves a subthreshold Cs(+)-sensitive conductance in neostriatal neurons.
Pacheco-Cano MT; Bargas J; Hernández-López S; Tapia D; Galarraga E
Exp Brain Res; 1996 Jul; 110(2):205-11. PubMed ID: 8836685
[TBL] [Abstract][Full Text] [Related]
60. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
Ralph RJ; Caine SB
J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
